1. Home
  2. SYM vs HALO Comparison

SYM vs HALO Comparison

Compare SYM & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Symbotic Inc.

SYM

Symbotic Inc.

HOLD

Current Price

$41.14

Market Cap

7.5B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$68.22

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYM
HALO
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
8.1B
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
SYM
HALO
Price
$41.14
$68.22
Analyst Decision
Buy
Buy
Analyst Count
12
11
Target Price
$62.50
$78.64
AVG Volume (30 Days)
2.5M
1.5M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
1.22
Revenue
$2,246,922,000.00
$151,862,000.00
Revenue This Year
$24.75
$28.24
Revenue Next Year
$27.90
$12.56
P/E Ratio
$1,381.00
$55.63
Revenue Growth
25.65
N/A
52 Week Low
$37.45
$51.06
52 Week High
$87.88
$82.22

Technical Indicators

Market Signals
Indicator
SYM
HALO
Relative Strength Index (RSI) 37.27 48.43
Support Level N/A $66.31
Resistance Level $57.22 $70.54
Average True Range (ATR) 2.42 2.34
MACD -0.23 -0.25
Stochastic Oscillator 21.09 44.14

Price Performance

Historical Comparison
SYM
HALO

About SYM Symbotic Inc.

Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: